compared with the control groups 与对照组比较结果
Compared with the control group, the various indicators of the experimental group athletes taking medicine had significant differences.
比较实验组运动员服药前后的各项指标,以及与其对照组相比,均有显著性差异。
Results showed that rosiglitazone-treated patients had an odds ratio of 1.43 for MI and 1.64 for cardiovascular death compared with the control group.
结果表明接受罗格列酮治疗的患者对比对照控制组患者在心梗和心血管死亡上的优势比分别是1.43和1.64。
Compared with the control, majority treatments could promote the activity of hemicellulase, and the effect on the activity of pectinase was less than that of other two enzymes.
与对照相比,多数药剂处理后能促进半纤维素酶的活性,同时药剂对果胶酶活性的影响不如对其它两种酶活性的影响明显。
应用推荐